Press Release

You Are Currently Here:Home > Press Release

Aegis Life and Entos will use NTC’s proprietary Nanoplasmid™ plasmid DNA technology and manufacturing platform for the clinical and commercial production of their SARS-CoV-2 vaccine

As part of a new agreement with Nature Technology Corporation (NTC), Aegis Life and Entos will use NTC's proprietary Nanoplasmid™ plasmid DNA technology and manufacturing platform for the clinical and commercial production of their SARS-CoV-2 vaccine...

By |2020-10-30T03:57:54+00:00October 15th, 2020|Press Release|0 Comments

Poseida Therapeutics utilizes Nanoplasmid® technology to demonstrate increased transposition frequency

Poseida Therapeutics, Inc., (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today will present data related to its proprietary manufacturing process designed to optimize its CAR-T product candidates. The Company will also illustrate the impact of these optimizations with preclinical data and preliminary clinical analysis with a focus on P-BCMA-101, its autologous CAR-T product candidate for multiple myeloma. The findings will be presented today at CAR-TCR Digital Week 2020 being held September 14-17, 2020.

By |2020-10-30T03:45:07+00:00September 16th, 2020|Press Release|0 Comments

Deborah Moorad-Watts Appointed Chief Executive Officer

Nature Technology Corporation, a leading developer and provider of non-viral vectors, technologies and services for advancing gene and cell therapy and immunotherapy, announced today that Deborah Moorad-Watts, formerly Chief Business Officer, has been appointed Chief Executive Officer of the Company....

By |2020-10-28T21:11:23+00:00May 5th, 2020|Press Release|0 Comments
Go to Top